Combined SHP2 and ERK inhibition for the treatment of KRAS-driven Pancreatic Ductal AdenocarcinomaKatrin J. Ciecielski, Sara Mainardi, Alexandra Berninger et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2